HIV News and Research

RSS

Chiron grants a non-exclusive license to the German Red Cross

Chiron Corporation has announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and hepatitis C virus (HCV) technology for use in molecular probe "home brew" blood screening.

4 Oct 2004

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims’ bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length.

30 Sep 2004

Berkeley searches for AIDS cure in a Samoan indigenous tree

The University of California, Berkeley, has signed an agreement with the Samoan government to isolate from an indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa.

30 Sep 2004

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).

30 Sep 2004

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Women who take combination AIDS drugs not only have benefits for their own health but also may pass along high levels of the medication through breast-feeding, potentially protecting their infants from HIV infection

30 Sep 2004

Schwarzenegger signs AIDS Pharmacy Bill

The AIDS Healthcare Foundation (AHF) has praised Governor Schwarzenegger for signing AB 1367 (Darrell Steinberg, D, Sacramento John Laird, D, Santa Cruz).

29 Sep 2004

PAHO outlines health challenges ahead

Pan American Health Organization (PAHO) Director Dr. Mirta Roses today presented a report summarizing PAHO's work over the past year in the Americas, during a special session of a meeting of the region's ministers of health taking place at PAHO headquarters this week.

28 Sep 2004

South African sales of MedMira rapid HIV tests begin

MedMira Inc., the international market leader in rapid flow- through diagnostic technology announced today that it has begun shipment of its MiraWell(TM) Rapid HIV Test to its distributor.

26 Sep 2004

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Researchers targeted Nef, a protein responsible for accelerating the development of acquired immunodeficiency syndrome, or AIDS. Nef was targeted with small molecules synthesized by the researchers – molecules that disrupted Nef’s interaction with other proteins.

26 Sep 2004

Asia must tackle HIV in injecting drug users

Asian countries must adopt strategies to slow the spread of HIV among injecting drug users, urge researchers in this week's BMJ.

23 Sep 2004

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Dr Norelle Daly, from UQ’s Institute for Molecular Bioscience, is looking at the molecular structure of retrocyclin, a molecule with the ability to protect human cells from HIV infection.

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Glaxo drops appeal in AIDS drug pricing case

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward.

22 Sep 2004

Edible vaccine for HIV AIDS

Scientists from Novosibirsk are engaged in the development of an unusual vaccine which, apart from being less expensive to produce, safe and painless to administer, is also edible.

22 Sep 2004

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Challenging the notion that multidrug-resistant tuberculosis (MDR-TB) poses a low threat to populations, epidemiologists at the Harvard School of Public Health (HSPH) have constructed a mathematical model of the disease variant's potential course

20 Sep 2004

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have discovered a key mechanism in the brains of people with human immunodeficiency virus (HIV) dementia.

20 Sep 2004

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Urgent measures need to be taken to protect the public from contaminated blood transfusions

In the Western Pacific Region, transmission of HIV/AIDS and other infections such as hepatitis B and C through blood transfusion remains a serious threat. It is particularly acute in areas where prevalence of these diseases is high and access to safe blood is limited.

16 Sep 2004

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Dr Shigeru Omi, World Health Organization Regional Director for the Western Pacific, has warned of the danger of HIV "bridging" into the general population from infected individuals with high-risk behaviour unless countries and areas in the Region act now to avoid a major HIV/AIDS epidemic.

16 Sep 2004

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Republican and Democratic presidential campaign representatives today said their candidates will address the public health work force shortage, but they debated the need for sex education and federal regulation of tobacco

16 Sep 2004

HIV News and Research

Chiron grants a non-exclusive license to the German Red Cross

Circulation of ‘disaster myths’ in Haiti could hinder appropriate disposal of bodies

Berkeley searches for AIDS cure in a Samoan indigenous tree

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Schwarzenegger signs AIDS Pharmacy Bill

PAHO outlines health challenges ahead

South African sales of MedMira rapid HIV tests begin

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Asia must tackle HIV in injecting drug users

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Glaxo drops appeal in AIDS drug pricing case

Edible vaccine for HIV AIDS

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Discovery of dopamine terminal injury in brains of people with HIV dementia

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Urgent measures need to be taken to protect the public from contaminated blood transfusions

WHO urges Member States to act now to avoid a major HIV/AIDS epidemic

Public health issues, AIDS, sex education and federal tobacco regulation take center stage

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News